VITASPRING BIOMEDICAL CO., LTD. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b59e6e8e-7e13-4fdd-92e2-d63b757a7f3c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-02-01 – 2026-01-31 | evidence 0001640334-26-001082 |
| FY 2024 | $0 | 2024-02-01 – 2025-01-31 | evidence 0001640334-26-001019 |
| FY 2023 | $0 | 2023-02-01 – 2024-01-31 | evidence 0001640334-26-000426 |
| FY 2022 | $0 | 2022-02-01 – 2023-01-31 | evidence 0001640334-25-002237 |
| FY 2021 | $5.6M | 2021-02-01 – 2022-01-31 | evidence 0001697884-22-000006 |
| FY 2020 | $248.2k | 2020-02-01 – 2021-01-31 | evidence 0001697884-21-000003 |
| FY 2019 | $15.1k | 2019-02-01 – 2020-01-31 | evidence 0001697884-21-000003 |
| FY 2018 | $17.2k | 2018-02-04 – 2019-01-31 | evidence 0001697884-20-000013 |
| FY 2017 | $16.2k | 2017-02-01 – 2018-01-31 | evidence 0001697884-18-000009 |
| FY 2016 | $0 | 2016-02-01 – 2017-01-31 | evidence 0001697884-18-000009 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
VITASPRING BIOMEDICAL CO., LTD. — all facts · Net Income · Operating Income